IONIS PHARMACEUTICALS INC
IONS
63 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | May 13 9:20 PM | Monia Brett P | Proposed Sale | 100,000 | $78.01 | $7.8M | — | View → |
| May 4, 2026 | May 6 9:27 PM | Joseph LoscalzoDirector | Sale | 77,289 | $75.06 | $5.8M | 36,330(D) | View → |
| May 1, 2026 | May 5 8:30 PM | Joseph Klein IIIDirector | Sale | 10,111 | $73.51 | $743.2K | 11,014(D) | View → |
| May 4, 2026 | May 4 10:05 PM | LOSCALZO JOSEPH | Proposed Sale | 54,321 | $80.00 | $4.3M | — | View → |
| Apr 28, 2026 | Apr 30 8:21 PM | Joseph BaroldiEVP, Chief Business Officer | Sale | 1,626 | $71.79 | $116.7K | 44,909(D) | View → |
| Apr 28, 2026 | Apr 28 8:12 PM | Baroldi Joseph | Proposed Sale | 1,626 | $71.79 | $116.7K | — | View → |
| Apr 15, 2026 | Apr 17 11:19 PM | Lynne B ParshallDirector | Sale | 5,000 | $76.27 | $381.4K | 51,344(D) | View → |
| Apr 16, 2026 | Apr 17 11:19 PM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Sale | 4,902 | $75.17 | $368.5K | 23,713(D) | View → |
| Apr 16, 2026 | Apr 17 11:19 PM | Brian BirchlerEVP, Corp and Development Ops | Sale | 973 | $75.04 | $73.0K | 67,500(D) | View → |
| Apr 16, 2026 | Apr 17 11:19 PM | Joseph BaroldiEVP, Chief Business Officer | Sale | 5,619 | $74.56 | $419.0K | 46,535(D) | View → |
| Apr 16, 2026 | Apr 16 10:49 PM | Jenne Kyle | Proposed Sale | 4,902 | $75.40 | $369.6K | — | View → |
| Apr 16, 2026 | Apr 16 10:47 PM | Birchler Brian | Proposed Sale | 973 | $75.40 | $73.4K | — | View → |
| Apr 16, 2026 | Apr 16 10:45 PM | Baroldi Joseph | Proposed Sale | 5,619 | $75.40 | $423.7K | — | View → |
| Apr 1, 2026 | Apr 2 11:43 PM | Joseph Klein IIIDirector | Sale | 22,321 | $75.55 | $1.7M | 11,014(D) | View → |
| Apr 2, 2026 | Apr 2 11:43 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Sale | 6,193 | $74.05 | $458.6K | 16,348(D) | View → |
| Mar 3, 2026 | Mar 31 9:28 PM | Diaz Allene M. | Proposed Sale | 68,800 | $79.50 | $5.5M | — | View → |
| Mar 19, 2026 | Mar 24 8:43 PM | Schneider Eugene | Proposed Sale | 5,812 | $70.97 | $412.5K | — | View → |
| Mar 19, 2026 | Mar 23 11:36 PM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Sale | 5,812 | $70.97 | $412.5K | 63,890(D) | View → |
| Mar 19, 2026 | Mar 19 8:01 PM | Schneider Eugene | Proposed Sale | 5,812 | $70.97 | $412.5K | — | View → |
| Mar 17, 2026 | Mar 18 9:19 PM | HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | 10,172 | $73.21 | $744.7K | 82,660(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 11 8:19 PM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 114,351 | $60.89 | 34,103(D) | View → |
| Mar 10, 2026 | Mar 11 8:18 PM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Option Exercise | 37,277 | $46.10 | 32,601(D) | View → |
| Mar 4, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 200 | $38.06 | 10,968(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 832 | $38.06 | 11,168(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph Klein IIIDirector | Option Exercise | 16,000 | $42.88 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Allene M. DiazDirector | Option Exercise | 40,321 | $41.08 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Option Exercise | 20,106 | $52.87 | 8,877(D) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Mar 4, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 439 | $56.78 | 3,866(I) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 1,699 | $56.78 | 4,104(I) | View → |
| Feb 2, 2026 | Feb 4 9:06 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Michael J. YangDirector | Option Exercise | 1,930 | — | 7,150(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Grant/Award | 35,700 | $0.00 | 611(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Option Exercise | 21,477 | — | 386(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Option Exercise | 21,685 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Option Exercise | 21,473 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Grant/Award | 156,585 | $0.00 | 205,719(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 89,145 | — | 163,014(D) | View → |